Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Centex Studies, Inc.
mi
from
Lake Charles, LA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Centex Studies, Inc.
mi
from
Lake Charles, LA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Women Under Study, LLC
mi
from
New Orleans, LA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Women Under Study, LLC
mi
from
New Orleans, LA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Novex Clinical Research, LLC
mi
from
New Bedford, MA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Novex Clinical Research, LLC
mi
from
New Bedford, MA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Bay State Clinical Trials, Inc.
mi
from
Watertown, MA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Bay State Clinical Trials, Inc.
mi
from
Watertown, MA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
IHA Chelsea Family & Internal Medicine
mi
from
Chelsea, MI
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
IHA Chelsea Family & Internal Medicine
mi
from
Chelsea, MI
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute of Michigan,
mi
from
Chesterfield, MI
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute of Michigan,
mi
from
Chesterfield, MI
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Center for Digestive Health
mi
from
Troy, MI
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Center for Digestive Health
mi
from
Troy, MI
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ridgeview Research
mi
from
Chaska, MN
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ridgeview Research
mi
from
Chaska, MN
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
The Center For Clinical Trials
mi
from
Biloxi, MS
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
The Center For Clinical Trials
mi
from
Biloxi, MS
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Gastrointestinal Associates, P.A.
mi
from
Jackson, MS
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Gastrointestinal Associates, P.A.
mi
from
Jackson, MS
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Montana Health Research Institute, Inc.
mi
from
Billings, MT
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Montana Health Research Institute, Inc.
mi
from
Billings, MT
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Internal Medical Associates Of Grand Island, P.C
mi
from
Grand Island, NE
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Internal Medical Associates Of Grand Island, P.C
mi
from
Grand Island, NE
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Quality Clinical Research, Inc.
mi
from
Omaha, NE
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
St. Luke's Hospital
mi
from
New York, NY
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
St. Luke's Hospital
mi
from
New York, NY
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
MediSpect Medical Research, LLC
mi
from
Boone, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
MediSpect Medical Research, LLC
mi
from
Boone, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of North Carolina, LLC
mi
from
Cary, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of North Carolina, LLC
mi
from
Cary, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Carolina Digestive Health Associates
mi
from
Charlotte, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Carolina Digestive Health Associates
mi
from
Charlotte, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
On Site Clinical, LLC
mi
from
Charlotte, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
On Site Clinical, LLC
mi
from
Charlotte, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Carolina Digestive Health Associates
mi
from
Davidson, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Carolina Digestive Health Associates
mi
from
Davidson, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Cumberland Research Associates
mi
from
Fayetteville, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Cumberland Research Associates
mi
from
Fayetteville, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Medoff Medical / Vital re:Search
mi
from
Greensboro, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Medoff Medical / Vital re:Search
mi
from
Greensboro, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
LeBauer Research Associates
mi
from
Greensboro, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
LeBauer Research Associates
mi
from
Greensboro, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Wake Research Associates, LLC
mi
from
Raleigh, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Hometown Urgent Care and Occupational Health
mi
from
Columbus, OH
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Hometown Urgent Care and Occupational Health
mi
from
Columbus, OH
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Great Lakes Gastroenterology
mi
from
Mentor, OH
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Great Lakes Gastroenterology
mi
from
Mentor, OH
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Central Sooner Research
mi
from
Norman, OK
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Central Sooner Research
mi
from
Norman, OK
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Oklahoma Foundation for Digestive Research
mi
from
Oklahoma City, OK
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Oklahoma Foundation for Digestive Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Lynn Health Science Institute
mi
from
Oklahoma City, OK
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Options Health Research
mi
from
Tulsa, OK
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Options Health Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Consultants in Gastroenterology
mi
from
Columbia, SC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Consultants in Gastroenterology
mi
from
Columbia, SC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Southeast Medical Research
mi
from
North Charleston, SC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Southeast Medical Research
mi
from
North Charleston, SC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Palmetto Clinical Research
mi
from
Summerville, SC
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Palmetto Clinical Research
mi
from
Summerville, SC
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
ClinSearch, LLC
mi
from
Chattanooga, TN
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Chattanooga Medical Research, LLC
mi
from
Chattanooga, TN
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Chattanooga Medical Research, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Franklin Gastroenterology
mi
from
Franklin, TN
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Franklin Gastroenterology
mi
from
Franklin, TN
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Memphis Gastroenterology Group
mi
from
Germantown, TN
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Memphis Gastroenterology Group
mi
from
Germantown, TN
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Associates in Gastroenterology
mi
from
Hermitage, TN
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Associates in Gastroenterology
mi
from
Hermitage, TN
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
DCT- AACT, LLC dba Discovery Clinical Trials
mi
from
Austin, TX
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
DCT- AACT, LLC dba Discovery Clinical Trials
mi
from
Austin, TX
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Austin Center for Clinical Research
mi
from
Austin, TX
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Austin Center for Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Texas Tech Medical Center
mi
from
El Paso, TX
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Texas Tech Medical Center
mi
from
El Paso, TX
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Centex Studies Inc
mi
from
Houston, TX
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Centex Studies Inc
mi
from
Houston, TX
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
North Texas Family Medicine
mi
from
Plano, TX
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
North Texas Family Medicine
mi
from
Plano, TX
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Quality Research
mi
from
San Antonio, TX
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Quality Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Physician PrimeCare Research Institute, PLLC dba Health Texas Research Institute
mi
from
San Antonio, TX
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Physician PrimeCare Research Institute, PLLC dba Health Texas Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Pioneer Research Solutions
mi
from
Sugar Land, TX
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Pioneer Research Solutions
mi
from
Sugar Land, TX
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
New River Valley Research Institute
mi
from
Christiansburg, VA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
New River Valley Research Institute
mi
from
Christiansburg, VA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Blue Ridge Medical Research / Gastroenterology Associates of Central Virginia
mi
from
Lynchburg, VA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Blue Ridge Medical Research / Gastroenterology Associates of Central Virginia
mi
from
Lynchburg, VA
Click here to add this to my saved trials